The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - MedicX Fund

4 Mar 2019 15:17

RNS Number : 7874R
Smith & Williamson Investment Mngmt
04 March 2019
 

FORM 8.3

 

DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Smith and Williamson Investment Management

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

01/03/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

Primary Health Properties Plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary NPV

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,054,997

0.92%

(2) Cash-settled derivatives:

 

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

 

TOTAL:

4,054,997

0.92%

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (£)

ORD NPV

Sale

150,000

0.9401

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

04/03/2019

Contact name:

Isha Gupta

Compliance Officer

Smith & Williamson

Telephone number:

020 7131 8192

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETCKQDDPBKDPNK
Date   Source Headline
20th Sep 20124:48 pmRNSScrip Dividend Declaration
19th Sep 20124:33 pmRNSAcquisition
22nd Aug 20125:29 pmRNSScrip Calculation Price
21st Aug 20121:42 pmRNSPublication of Circular to Shareholders
16th Aug 20127:00 amRNSDirector Declaration
13th Aug 201211:30 amRNSSale of ordinary shares out of treasury
8th Aug 20123:57 pmRNSSale of ordinary shares
8th Aug 201211:26 amRNSInterim Management Statement
30th Jul 20126:17 pmRNSNotice of dividend
23rd Jul 20127:01 amRNSInvestment Advisory Agreement Renewal
23rd Jul 20127:00 amRNSAcquisition
3rd Jul 201211:00 amRNSAcquisition
3rd Jul 20129:58 amRNSAcquisition
2nd Jul 20127:58 amRNS2. Allotment of shares to the Investment Adviser
2nd Jul 20127:52 amRNSAllotment of shares to directors
2nd Jul 20127:52 amRNSTotal Voting Rights
26th Jun 20123:55 pmRNSScrip Dividend Declaration
13th Jun 20125:43 pmRNSSale of ordinary shares out of treasury
11th Jun 20124:12 pmRNSCompletion of new primary healthcare centre
6th Jun 20122:58 pmRNSNotification of major interest in shares
6th Jun 201212:36 pmRNSNotification of major interest in shares
6th Jun 201211:31 amRNSTotal Voting Rights
31st May 20125:21 pmRNSSale of ordinary shares out of treasury
28th May 20127:00 amRNSResults for the six months to 31 March 2012
23rd May 20125:13 pmRNSScrip Calculation Price for June 2012 Dividend
23rd May 20127:00 amRNSAcquisition of new primary care medical centre
22nd May 20122:47 pmRNSScrip Dividend Scheme
21st May 20128:32 amRNSPortfolio update
4th May 20124:41 pmRNSSale of ordinary shares out of treasury
4th May 20124:32 pmRNSTotal Voting Rights
30th Apr 20127:00 amRNSNotice of dividend
27th Apr 20125:23 pmRNSSale of ordinary shares out of treasury
2nd Apr 20126:00 pmRNSAllotment of shares to Investment Adviser
2nd Apr 20125:59 pmRNSTotal Voting Rights
2nd Apr 20125:59 pmRNSAllotment of shares to MXF Directors
30th Mar 20123:12 pmRNSAcquisition of new primary care medical centre
29th Mar 20124:59 pmRNSSale of ordinary shares out of treasury
29th Mar 20127:00 amRNSScrip Dividend Declaration
27th Mar 20125:32 pmRNSSale of ordinary shares held in treasury
28th Feb 20126:18 pmRNSNotification of Major Interests in Shares
27th Feb 20124:07 pmRNSNotification of major interest in shares
23rd Feb 20125:11 pmRNSResults of Issue
23rd Feb 201212:37 pmRNSAcquisition
23rd Feb 20127:00 amRNSScrip Dividend Scheme
22nd Feb 20125:52 pmRNSNotification of major interest in shares
21st Feb 20124:49 pmRNSCircular to Shareholders/Scrip Dividend Scheme
20th Feb 201211:53 amRNSPlacing Terms and Conditions
17th Feb 20124:43 pmRNSExtraordinary General Meeting results
17th Feb 20124:38 pmRNSAnnual General Meeting results
17th Feb 20124:38 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.